Drug Shortage Report for CARDIOLITE

Last updated on 2022-01-14 History
Report ID 142747
Drug Identification Number 02328003
Brand name CARDIOLITE
Common or Proper name Kit for the Preparation of Technetium Tc99m Sestamibi for Injection
Company Name LANTHEUS MI CANADA INC
Market Status MARKETED
Active Ingredient(s) TETRAKIS [CU
Strength(s) 1MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size Kits of 2, 5, 20, or 30 vials
ATC code V09GX
ATC description
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2021-09-01
Actual start date 2021-08-27
Estimated end date 2022-02-15
Actual end date
Shortage status Actual shortage
Updated date 2022-01-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1111 DR. FREDERIK-PHILIPS BLVD., SUITE 600
MONTREAL, QUEBEC
CANADA H4M 2X6
Company contact information lmicanada@lantheus.com 1-800-811-5500

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2022-01-14 French Compare
v8 2022-01-14 English Compare
v7 2021-10-18 French Compare
v6 2021-10-18 English Compare
v5 2021-09-02 English Compare
v4 2021-07-19 French Compare
v3 2021-07-19 English Compare
v2 2021-07-19 French Compare
v1 2021-07-19 English Compare

Showing 1 to 9 of 9